VaxGen, Inc.
VaxGen, Inc. company was founded in 1995 and is based in South San Francisco, California. VaxGen, Inc., (VaxGen) is a biopharmaceutical company. VaxGen is focused on the development, manufacture and commercialization of biologic products for the treatment of human disease. The Company owns a state-of-the-art biopharmaceutical manufacturing facility with a 1,000-liter bioreactor that can be used to make cell culture or microbial biologic products. The Company has ended all product development activities and sold or otherwise terminated its drug development programs. On March 28, 2008, the Company entered into a Termination of Merger Agreement, Acknowledgment and Amendment to Loan Agreement and Secured Promissory Note, or Termination Agreement and Amendment, terminating immediately the Merger Agreement and amending the terms of VaxGen’s bridge loan to Raven.
Contact Details
Office Address
VaxGen, Inc.
379 Oyster Point Boulevard, Suite 10
South San Francisco, CA, USA 94080
Phone: (650) 624-1000
Fax: (650) 624-4785
Executives
Chief Operating Officer & Chief Financial Officer
Mr. James Panek
Chief Scientific Officer
Dr. Jennie P. Mather
.webp)
.webp)
.webp)
.webp)
.webp)
